| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3857225 | Journal of Renal Nutrition | 2008 | 8 Pages |
Abstract
The present study demonstrates an altered DBP allele frequency in hemodialysis patients, compared with the general population. More importantly, vitamin D intake differs depending on the DBP polymorphism, and is greatest for end-stage renal disease patients with a DBP 2-2 phenotype. Therefore, vitamin D treatment deserves more careful monitoring among DBP 2-2 patients with end-stage renal disease.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Marijn M. MD, Griet L. PhD, Raymond MD, PhD, Wim MD, PhD, Youri E. MD, PhD, Frédéric MT, Charline MB, Ch B, Joris R. MD, PhD,